{
  "first_published_at": "2009-06-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON088100", 
  "title": "Counterfeit medicines: patient guidance for distribution via pharmacies", 
  "tags": "{\"parsed_therapeutic\": [\"dentistry\"], \"Audience:\": [\"Primary care\", \"Secondary care\", \"Dentists\"]}", 
  "_document_number": 261, 
  "label": null, 
  "icon": null, 
  "therapeutic_area": [
    "dentistry"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Counterfeit medicines: patient guidance for distribution via pharmacies</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: June 2009</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--Although the number of counterfeit medicines and medical devices entering the legitimate supply chain in the UK is small, pharmacists have an important role in helping prevent counterfeits reaching patients-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Although the number of counterfeit medicines and medical devices entering the legitimate supply chain in the UK is small, pharmacists have an important role in helping prevent counterfeits reaching patients.</p><p>On ten occasions since 2004 we have recalled batches of medicines where counterfeits are likely to have reached patients through the legitimate supply chain, the last of which was in May 2009. On three other occasions in the past 2 years, counterfeit medical devices have been identified as being sold to UK consumers. Counterfeit medicines and medical devices are a health risk to patients because they are not subject to the rigorous quality standards required of legitimate manufacture.</p><p>See risk of <a href=\"ssLINK/CON088110\" target=\"_blank\">counterfeit insulin pen needles</a></p><p>See also <a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/Drugalerts/CON046565\" title=\"Class 2 Drug Alert (Action within 48 hours): Allen and Hanburys - Seretide 250 Evohaler (25 micrograms of salmeterol xinafoate and 250 micrograms of fluticasone propionate per actuation) - EL (09)A/12\">Class 2 Drug Alert (Action within 48 hours): Allen and Hanburys - Seretide 250 Evohaler (25 micrograms of salmeterol xinafoate and 250 micrograms of fluticasone propionate per actuation) - EL (09)A/12</a> for a drug alert for Seretide 250 Evohaler due to possible presence of counterfeit inhalers in the supply chain (May 12, 2009).</p><p>In recent years there has been an explosion of websites offering medicines for sale online, which has sparked much debate. The risk of obtaining substandard or counterfeit medication substantially increases when prescription-only products are purchased from unauthorised sources.</p><p>We are urging key stakeholders to assist in tackling these issues. Initiatives under way include awareness and providing 24-hour reporting hotlines.</p><h2>Postcard guidance for patients</h2><p>As part of a long-term public awareness campaign about counterfeit medication and its dangers, the MHRA and the Royal Pharmaceutical Society of Great Britain (RPSGB) have produced new guidance for patients, which is being issued through pharmacies. The pilot project (launched May 2009) involves every pharmacy in Great Britain distributing 50 copies of the guidance leaflets in patients&rsquo; prescription bags.</p><p>The guidance has been developed in conjunction with patient groups. The postcard-size leaflet offers practical advice about the safest way to purchase medicines as well as explaining what counterfeit medications are, how to minimise the risk of buying them, and what to do if patients suspect that they have been sold or supplied counterfeits. It particularly focuses on the increased risks involved with obtaining medication online (see leaflet images).</p><h2>Campaigning</h2><p>We also collaborated with Pfizer and patient groups earlier this year to produce a hard-hitting cinema campaign designed to shock people into discussion about the dangers of obtaining medicine online. The footage shows a man regurgitating a rat (to reflect a previous discovery of rat poison in a fake medicine) after taking a pill ordered online.</p><p>Future MHRA campaigns will target consumers who may be at particular risk such as online shoppers, men&rsquo;s health forums, slimming clubs, and smoking-cessation bodies.</p><p>See the <a href=\"http://www.realdanger.co.uk/\" target=\"_blank\" title=\"cinema campaign online\">cinema campaign online</a></p><h2>Professional guidance</h2><p>The new patient postcard complements updated guidance for pharmacists and dispensing doctors on counterfeit medicines that was published in February 2009 through collaboration between the MHRA, RPSGB, and Dispensing Doctors&rsquo; Association.</p><p><a href=\"http://www.mhra.gov.uk/home/groups/ei/documents/websiteresources/con2033091.pdf\" title=\"Counterfeit Medicines Advice for Healthcare Professionals\">Counterfeit Medicines Advice for Healthcare Professionals</a></p><p>This pharmacist guidance explains the background to the production and supply of counterfeit medicines, and offers advice on steps pharmacists should take if they encounter a suspected counterfeit medicine. These steps include reporting suspected illegal websites to the MHRA to help safeguard public health.</p><p>Similar guidance is being developed for doctors and nurses in association with the General Medical Council, British Medical Association, and Royal College of Nursing.</p><p>If a patient is concerned that they have a counterfeit medicine, then the pharmacist or dispensing doctor should make a record (noting if possible the patient&rsquo;s contact details, reason for the suspicion, product name, dose, batch number, and expiry date). They should then inform the MHRA immediately: email <a href=\"mailto:counterfeits@mhra.gsi.gov.uk\" title=\"Email counterfeits\">counterfeits@mhra.gsi.gov.uk</a>; call 020 7084 2701 (24 hours); or report online at <a href=\"www.mhra.gov.uk\" title=\"MHRA\">www.mhra.gov.uk</a></p><p>Healthcare professionals and the wider public can report suspected side-effects from a medicine that they suspect to be fake by completing a <a href=\"http://www.yellowcard.gov.uk\" target=\"_blank\">Yellow Card</a>.</p><h2>Online pharmacies</h2><p>The internet provides counterfeiters with easy access to consumers and markets. A <a href=\"http://www.healthcarerepublic.com/news/935192/Exclusive-One-four-GPs-treats-patients-reaction-online-medicine/\" target=\"_blank\">recent GP newspaper survey</a> has found that one in four GPs has treated patients for adverse reactions to medicines bought online. The RPSGB has developed an internet pharmacy logo to help the public identify a bona fide website that is operated by a registered pharmacy in Britain.</p><p>See <a href=\"http://www.rpsgb.org/registrationandsupport/registration/internetpharmacylogo.html\" target=\"_blank\" title=\"Internet pharmacy logo\">Internet pharmacy logo</a></p><p><img border=\"0\" src=\"/idcm2/groups/dsu/documents/websiteresources/con088101.jpg\"></p><p>Further discussions between the MHRA and General Medical Council will look at ways to tighten current legislation and systems for the online supply of medicines. A particular focus will be online consultations, which have potential to be misused by patients who are unsuitable for a particular treatment, or by unscrupulous organisations that sell medicines without the involvement of a healthcare professional.</p><p><img border=\"0\" src=\"/idcm2/groups/dsu/documents/websiteresources/con088102.jpg\"></p><p><strong>Further MHRA information:</strong></p><p><a href=\"http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Adviceandinformationforconsumers/BuyingmedicinesovertheInternet/index.htm\" title=\"Risks of buying medicines over the internet\">Risks of buying medicines over the internet</a></p><p><a href=\"http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Adviceandinformationforconsumers/Counterfeitmedicinesanddevices/index.htm\" title=\"Counterfeit medicines and devices\">Counterfeit medicines and devices</a></p><p><a href=\"http://www.mhra.gov.uk/Howweregulate/Medicines/Enforcingthelaw/index.htm\" title=\"Enforcing the law\">Enforcing the law</a></p><p><strong>See also:</strong></p><p><a href=\"http://www.rpsgb.org/\" target=\"_blank\" title=\"Royal Pharmaceutical Society of Great Britain\">Royal Pharmaceutical Society of Great Britain</a></p><p><a href=\"http://www.dispensingdoctor.org/\" title=\"Dispensing Doctors&rsquo; Association\">Dispensing Doctors&rsquo; Association</a></p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update June 2009, vol 2 issue 11: 9.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Although the number of counterfeit medicines and medical devices entering the legitimate supply chain in the UK is small, pharmacists have an important role in helping prevent counterfeits reaching patients.</p><p>On ten occasions since 2004 we have recalled batches of medicines where counterfeits are likely to have reached patients through the legitimate supply chain, the last of which was in May 2009. On three other occasions in the past 2 years, counterfeit medical devices have been identified as being sold to UK consumers. Counterfeit medicines and medical devices are a health risk to patients because they are not subject to the rigorous quality standards required of legitimate manufacture.</p><p>See risk of <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON088110\" target=\"_blank\">counterfeit insulin pen needles</a></p><p>See also <a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/Drugalerts/CON046565\" title=\"Class 2 Drug Alert (Action within 48 hours): Allen and Hanburys - Seretide 250 Evohaler (25 micrograms of salmeterol xinafoate and 250 micrograms of fluticasone propionate per actuation) - EL (09)A/12\">Class 2 Drug Alert (Action within 48 hours): Allen and Hanburys - Seretide 250 Evohaler (25 micrograms of salmeterol xinafoate and 250 micrograms of fluticasone propionate per actuation) - EL (09)A/12</a> for a drug alert for Seretide 250 Evohaler due to possible presence of counterfeit inhalers in the supply chain (May 12, 2009).</p><p>In recent years there has been an explosion of websites offering medicines for sale online, which has sparked much debate. The risk of obtaining substandard or counterfeit medication substantially increases when prescription-only products are purchased from unauthorised sources.</p><p>We are urging key stakeholders to assist in tackling these issues. Initiatives under way include awareness and providing 24-hour reporting hotlines.</p><h2>Postcard guidance for patients</h2><p>As part of a long-term public awareness campaign about counterfeit medication and its dangers, the MHRA and the Royal Pharmaceutical Society of Great Britain (RPSGB) have produced new guidance for patients, which is being issued through pharmacies. The pilot project (launched May 2009) involves every pharmacy in Great Britain distributing 50 copies of the guidance leaflets in patients&#8217; prescription bags.</p><p>The guidance has been developed in conjunction with patient groups. The postcard-size leaflet offers practical advice about the safest way to purchase medicines as well as explaining what counterfeit medications are, how to minimise the risk of buying them, and what to do if patients suspect that they have been sold or supplied counterfeits. It particularly focuses on the increased risks involved with obtaining medication online (see leaflet images).</p><h2>Campaigning</h2><p>We also collaborated with Pfizer and patient groups earlier this year to produce a hard-hitting cinema campaign designed to shock people into discussion about the dangers of obtaining medicine online. The footage shows a man regurgitating a rat (to reflect a previous discovery of rat poison in a fake medicine) after taking a pill ordered online.</p><p>Future MHRA campaigns will target consumers who may be at particular risk such as online shoppers, men&#8217;s health forums, slimming clubs, and smoking-cessation bodies.</p><p>See the <a href=\"http://www.realdanger.co.uk/\" target=\"_blank\" title=\"cinema campaign online\">cinema campaign online</a></p><h2>Professional guidance</h2><p>The new patient postcard complements updated guidance for pharmacists and dispensing doctors on counterfeit medicines that was published in February 2009 through collaboration between the MHRA, RPSGB, and Dispensing Doctors&#8217; Association.</p><p><a href=\"http://www.mhra.gov.uk/home/groups/ei/documents/websiteresources/con2033091.pdf\" title=\"Counterfeit Medicines Advice for Healthcare Professionals\">Counterfeit Medicines Advice for Healthcare Professionals</a></p><p>This pharmacist guidance explains the background to the production and supply of counterfeit medicines, and offers advice on steps pharmacists should take if they encounter a suspected counterfeit medicine. These steps include reporting suspected illegal websites to the MHRA to help safeguard public health.</p><p>Similar guidance is being developed for doctors and nurses in association with the General Medical Council, British Medical Association, and Royal College of Nursing.</p><p>If a patient is concerned that they have a counterfeit medicine, then the pharmacist or dispensing doctor should make a record (noting if possible the patient&#8217;s contact details, reason for the suspicion, product name, dose, batch number, and expiry date). They should then inform the MHRA immediately: email <a href=\"mailto:counterfeits@mhra.gsi.gov.uk\" title=\"Email counterfeits\">counterfeits@mhra.gsi.gov.uk</a>; call 020 7084 2701 (24 hours); or report online at <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/www.mhra.gov.uk\" title=\"MHRA\">www.mhra.gov.uk</a></p><p>Healthcare professionals and the wider public can report suspected side-effects from a medicine that they suspect to be fake by completing a <a href=\"http://www.yellowcard.gov.uk\" target=\"_blank\">Yellow Card</a>.</p><h2>Online pharmacies</h2><p>The internet provides counterfeiters with easy access to consumers and markets. A <a href=\"http://www.healthcarerepublic.com/news/935192/Exclusive-One-four-GPs-treats-patients-reaction-online-medicine/\" target=\"_blank\">recent GP newspaper survey</a> has found that one in four GPs has treated patients for adverse reactions to medicines bought online. The RPSGB has developed an internet pharmacy logo to help the public identify a bona fide website that is operated by a registered pharmacy in Britain.</p><p>See <a href=\"http://www.rpsgb.org/registrationandsupport/registration/internetpharmacylogo.html\" target=\"_blank\" title=\"Internet pharmacy logo\">Internet pharmacy logo</a></p><p><img border=\"0\" src=\"http://www.mhra.gov.uk/idcm2/groups/dsu/documents/websiteresources/con088101.jpg\" alt=\"Registered Pharmacy Logo\"></p><p>Further discussions between the MHRA and General Medical Council will look at ways to tighten current legislation and systems for the online supply of medicines. A particular focus will be online consultations, which have potential to be misused by patients who are unsuitable for a particular treatment, or by unscrupulous organisations that sell medicines without the involvement of a healthcare professional.</p><p><img border=\"0\" src=\"http://www.mhra.gov.uk/idcm2/groups/dsu/documents/websiteresources/con088102.jpg\" alt=\"Is your medicine safe\"></p><p><strong>Further MHRA information:</strong></p><p><a href=\"http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Adviceandinformationforconsumers/BuyingmedicinesovertheInternet/index.htm\" title=\"Risks of buying medicines over the internet\">Risks of buying medicines over the internet</a></p><p><a href=\"http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Adviceandinformationforconsumers/Counterfeitmedicinesanddevices/index.htm\" title=\"Counterfeit medicines and devices\">Counterfeit medicines and devices</a></p><p><a href=\"http://www.mhra.gov.uk/Howweregulate/Medicines/Enforcingthelaw/index.htm\" title=\"Enforcing the law\">Enforcing the law</a></p><p><strong>See also:</strong></p><p><a href=\"http://www.rpsgb.org/\" target=\"_blank\" title=\"Royal Pharmaceutical Society of Great Britain\">Royal Pharmaceutical Society of Great Britain</a></p><p><a href=\"http://www.dispensingdoctor.org/\" title=\"Dispensing Doctors&#8217; Association\">Dispensing Doctors&#8217; Association</a></p><p>&#160;</p><p><em>Article citation: Drug Safety Update June 2009, vol 2 issue 11: 9.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2009-06-01", 
  "date_last_modified": "2010-08-10", 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "Counterfeit Medicines Advice for Healthcare Professionals", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/ei/documents/websiteresources/con2033091.pdf", 
      "filename": "downloads/17800b690cf6e72d855a8a98ae28b867a7c2f505/con2033091.pdf", 
      "original_filename": "con2033091.pdf"
    }, 
    {
      "content_type": "image/jpeg", 
      "title": "Registered Pharmacy Logo", 
      "assetid": 1, 
      "original_url": "http://www.mhra.gov.uk/idcm2/groups/dsu/documents/websiteresources/con088101.jpg", 
      "filename": "downloads/eb8ae666509cb934eac2229a3d2441a2c2eb31cd/con088101.jpg", 
      "original_filename": "con088101.jpg"
    }, 
    {
      "content_type": "image/jpeg", 
      "title": "Is your medicine safe", 
      "assetid": 2, 
      "original_url": "http://www.mhra.gov.uk/idcm2/groups/dsu/documents/websiteresources/con088102.jpg", 
      "filename": "downloads/40fa4231b9011c437fdf6209c2fc516ab674081a/con088102.jpg", 
      "original_filename": "con088102.jpg"
    }
  ], 
  "_item_id": 261, 
  "summary": "", 
  "body": "Article date: June 2009\n\nAlthough the number of counterfeit medicines and medical devices entering the legitimate supply chain in the UK is small, pharmacists have an important role in helping prevent counterfeits reaching patients.\n\nOn ten occasions since 2004 we have recalled batches of medicines where counterfeits are likely to have reached patients through the legitimate supply chain, the last of which was in May 2009. On three other occasions in the past 2 years, counterfeit medical devices have been identified as being sold to UK consumers. Counterfeit medicines and medical devices are a health risk to patients because they are not subject to the rigorous quality standards required of legitimate manufacture.\n\nSee risk of [counterfeit insulin pen needles](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON088110)\n\nSee also [Class 2 Drug Alert (Action within 48 hours): Allen and Hanburys - Seretide 250 Evohaler (25 micrograms of salmeterol xinafoate and 250 micrograms of fluticasone propionate per actuation) - EL (09)A/12](http://www.mhra.gov.uk/Publications/Safetywarnings/Drugalerts/CON046565) for a drug alert for Seretide 250 Evohaler due to possible presence of counterfeit inhalers in the supply chain (May 12, 2009).\n\nIn recent years there has been an explosion of websites offering medicines for sale online, which has sparked much debate. The risk of obtaining substandard or counterfeit medication substantially increases when prescription-only products are purchased from unauthorised sources.\n\nWe are urging key stakeholders to assist in tackling these issues. Initiatives under way include awareness and providing 24-hour reporting hotlines.\n\n## Postcard guidance for patients\n\nAs part of a long-term public awareness campaign about counterfeit medication and its dangers, the MHRA and the Royal Pharmaceutical Society of Great Britain (RPSGB) have produced new guidance for patients, which is being issued through pharmacies. The pilot project (launched May 2009) involves every pharmacy in Great Britain distributing 50 copies of the guidance leaflets in patients’ prescription bags.\n\nThe guidance has been developed in conjunction with patient groups. The postcard-size leaflet offers practical advice about the safest way to purchase medicines as well as explaining what counterfeit medications are, how to minimise the risk of buying them, and what to do if patients suspect that they have been sold or supplied counterfeits. It particularly focuses on the increased risks involved with obtaining medication online (see leaflet images).\n\n## Campaigning\n\nWe also collaborated with Pfizer and patient groups earlier this year to produce a hard-hitting cinema campaign designed to shock people into discussion about the dangers of obtaining medicine online. The footage shows a man regurgitating a rat (to reflect a previous discovery of rat poison in a fake medicine) after taking a pill ordered online.\n\nFuture MHRA campaigns will target consumers who may be at particular risk such as online shoppers, men’s health forums, slimming clubs, and smoking-cessation bodies.\n\nSee the [cinema campaign online](http://www.realdanger.co.uk/)\n\n## Professional guidance\n\nThe new patient postcard complements updated guidance for pharmacists and dispensing doctors on counterfeit medicines that was published in February 2009 through collaboration between the MHRA, RPSGB, and Dispensing Doctors’ Association.\n\n[ASSET_TAG](#ASSET0)\n\nThis pharmacist guidance explains the background to the production and supply of counterfeit medicines, and offers advice on steps pharmacists should take if they encounter a suspected counterfeit medicine. These steps include reporting suspected illegal websites to the MHRA to help safeguard public health.\n\nSimilar guidance is being developed for doctors and nurses in association with the General Medical Council, British Medical Association, and Royal College of Nursing.\n\nIf a patient is concerned that they have a counterfeit medicine, then the pharmacist or dispensing doctor should make a record (noting if possible the patient’s contact details, reason for the suspicion, product name, dose, batch number, and expiry date). They should then inform the MHRA immediately: email [counterfeits@mhra.gsi.gov.uk](mailto:counterfeits@mhra.gsi.gov.uk); call 020 7084 2701 (24 hours); or report online at [www.mhra.gov.uk](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/www.mhra.gov.uk)\n\nHealthcare professionals and the wider public can report suspected side-effects from a medicine that they suspect to be fake by completing a [Yellow Card](http://www.yellowcard.gov.uk).\n\n## Online pharmacies\n\nThe internet provides counterfeiters with easy access to consumers and markets. A [recent GP newspaper survey](http://www.healthcarerepublic.com/news/935192/Exclusive-One-four-GPs-treats-patients-reaction-online-medicine/) has found that one in four GPs has treated patients for adverse reactions to medicines bought online. The RPSGB has developed an internet pharmacy logo to help the public identify a bona fide website that is operated by a registered pharmacy in Britain.\n\nSee [Internet pharmacy logo](http://www.rpsgb.org/registrationandsupport/registration/internetpharmacylogo.html)\n\n![ASSET_TAG](#ASSET1)\n\nFurther discussions between the MHRA and General Medical Council will look at ways to tighten current legislation and systems for the online supply of medicines. A particular focus will be online consultations, which have potential to be misused by patients who are unsuitable for a particular treatment, or by unscrupulous organisations that sell medicines without the involvement of a healthcare professional.\n\n![ASSET_TAG](#ASSET2)\n\nFurther MHRA information:\n\n[Risks of buying medicines over the internet](http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Adviceandinformationforconsumers/BuyingmedicinesovertheInternet/index.htm)\n\n[Counterfeit medicines and devices](http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Adviceandinformationforconsumers/Counterfeitmedicinesanddevices/index.htm)\n\n[Enforcing the law](http://www.mhra.gov.uk/Howweregulate/Medicines/Enforcingthelaw/index.htm)\n\nSee also:\n\n[Royal Pharmaceutical Society of Great Britain](http://www.rpsgb.org/)\n\n[Dispensing Doctors’ Association](http://www.dispensingdoctor.org/)\n\n \n\nArticle citation: Drug Safety Update June 2009, vol 2 issue 11: 9.\n"
}